arrow
P

Posso, Margarita

Hospital del Mar Research Institute
H指数:0
被引数:63

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Exploring the Association of Cancer and Depression in Electronic Health Records: Combining Encoded Diagnosis and Mining Free-Text Clinical Notes

探索电子健康记录中癌症和抑郁症的关联: 结合编码诊断和挖掘自由文本临床笔记

2022-07-113
OA
Recommendations from the European Commission Initiative on Breast Cancer for multigene testing to guide the use of adjuvant chemotherapy in patients with early breast cancer, hormone receptor positive, HER-2 negative
2021-02-1825
OAAI
Effects of Environmental Factors on Severity and Mortality of COVID-19
2021-01-2036
OAAI
GRADE Guidelines 30: the GRADE approach to assessing the certainty of modeled evidence-An overview in the context of health decision-making
2021-01-0195
OAAI
Comorbidities and Mortality in Patients With COVID-19 Aged 60 Years and Older in a University Hospital in Spain
2020-11-0151
OAAI
Efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: A systematic review for the EAACI biologicals guidelines

dupilumab治疗中度至重度特应性皮炎的疗效和安全性: EAACI生物制剂指南的系统评价

2020-10-0440
OAAI
Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria: A systematic review for the EAACI Biologicals Guidelines

奥马珠单抗治疗慢性自发性荨麻疹的疗效和安全性: EAACI生物制剂指南的系统评价

2020-09-0754
OAAI
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma

生物制剂 (benralizumab,dupilumab和omalizumab) 治疗严重过敏性哮喘的有效性和安全性: EAACI指南的系统评价-关于在严重哮喘中使用生物制剂的建议

2020-05-1891
OAAI
Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines-Recommendations on the use of biologicals in severe asthma

dupilumab治疗重度哮喘的有效性和安全性: EAACI指南的系统评价-关于在重度哮喘中使用生物制剂的建议

2020-04-0164
OAAI
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma

生物制剂 (benralizumab,dupilumab,mepolizumab,omalizumab和reslizumab) 治疗严重嗜酸性粒细胞性哮喘的疗效和安全性

2020-02-24258
OAAI
Validation Of Cancer Diagnoses In Electronic Health Records: Results From The Information System For Research In Primary Care (SIDIAP) In Northeast Spain

电子健康记录中癌症诊断的验证: 西班牙东北部初级保健研究信息系统 (SIDIAP) 的结果

2019-12-0132
OAAI